Mukri, M.N.A. et al. 2018. Role of febuxostat in retarding progression of diabetic kidney disease with asymptomatic hyperuricemia: A 6-months open-label, randomized controlled trial. EXCLI Journal. 17, (Jun. 2018), 563–575. DOI:https://doi.org/10.17179/excli2018-1256.